These emerging medications , including Semaglutide , belong to a class of drugs called GLP-1 agents. Initially approved for managing high blood sugar, they operate by assisting the organism to release more insulin and limiting excessive glucose levels. Beyond diabetes, their ability to promote weight management has resulted to substantial interest